| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 09/08/2004 | CN1526450A Anticancer biological missile of internal radiating radium nuclein |
| 09/07/2004 | US6787335 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. |
| 09/02/2004 | WO2004074513A1 Methods for the prediction of suicidality during treatment |
| 09/02/2004 | WO2004074437A2 Compositions and methods for cancer immunotherapy |
| 09/02/2004 | WO2004074434A2 Methods and compositions for administering therapeutic and diagnostic agents |
| 09/02/2004 | WO2004074267A1 Trimeric macrocyclically substituted benzene derivatives |
| 09/02/2004 | WO2004073739A1 A method of diagnosis and treatment |
| 09/02/2004 | WO2004073648A2 Composition and methods for inhibiting cell survival |
| 09/02/2004 | WO2004073640A2 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 09/02/2004 | WO2004041070A3 Mri probes of membrane potential |
| 09/02/2004 | WO2003077727A3 Technetium-dipyridine complexes, and methods of use thereof |
| 09/02/2004 | US20040170603 Using radiolabeled annexin; radiotherapy for tumors |
| 09/02/2004 | US20040170566 Complex of metal compound and ligand; scavengers; magnetic resonance imaging; medical diagnosis |
| 09/02/2004 | US20040170560 Liposome confining prodrug, radioactive materials; multilayer; storage stability; antiinflammatory agents; infection therapy; antitumor agents imaging for diagnosis |
| 09/02/2004 | CA2516484A1 Methods for the prediction of suicidality during treatment |
| 09/02/2004 | CA2516467A1 Trimeric macrocyclically substituted benzene derivatives |
| 09/02/2004 | CA2516453A1 Composition and methods for inhibiting cell survival |
| 09/02/2004 | CA2516335A1 A method of diagnosis and treatment |
| 09/02/2004 | CA2516282A1 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 09/02/2004 | CA2514277A1 Methods and compositions for administering therapeutic and diagnostic agents |
| 09/01/2004 | EP1452543A2 RGD (ARG-GLY-ASP) coupled to (neuro)peptides |
| 09/01/2004 | EP1452185A1 Activation and production of radiolabeled particles |
| 09/01/2004 | EP1451219A1 Nuclear protein "shoca" - a component of the wnt signalling pathway |
| 09/01/2004 | EP1451176A2 Benzazepine derivatives and their use as 5-ht ligands |
| 09/01/2004 | EP1450864A2 Conjugates of macrocyclic metal complexes with biomolecules and the utilization thereof for producing agents for use in nmr diagnosis and radiodiagnosis and radiotherapy |
| 09/01/2004 | EP0674530B1 Radiolabeled polyhydric phenol compounds |
| 08/31/2004 | USRE38575 Diagnostic method for diabetes using C-13 labeled pyruvic acid |
| 08/31/2004 | US6783760 Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 08/26/2004 | WO2004072105A2 Iap-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods |
| 08/26/2004 | WO2004071571A1 Methods for the purification of stable radioiodine conjugates |
| 08/26/2004 | WO2004071505A2 Radiolabelled d-amino acids for use in diagnosis with spect and pet and systemic radionuclide therapy |
| 08/26/2004 | WO2004071425A2 The combined use of cruciferous indoles and chelators for the treatment of papillomavirus-related conditions |
| 08/26/2004 | WO2004026111B1 Flexible and/or elastic brachytherapy seed or strand |
| 08/26/2004 | US20040167336 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine |
| 08/26/2004 | US20040167330 Suitable targeting moieties are monoclonal antibodies, their fragments and recombinant derivatives such as single chain antibodies, diabodies, triabodies, humanized, human or chimeric variants but also peptides, aptamers, spiegelmers, nucleotides, anti sense oligomers |
| 08/26/2004 | US20040166062 direct visualization of the distribution of therapeutic agents in animal tissue, utilizing chemical shift magnetic resonance imaging (MRI). chemical ablation procedures provide optimal dosage to target tumors while limiting effects on nearby tissue |
| 08/26/2004 | US20040166060 Liposomal encapsulation of alpha particle emittors and uses thereof |
| 08/26/2004 | US20040166059 conjugates of a residue of vitamin B12 and a residue of a peptide or an amino acid comprising a radionuclide that are useful to image tumors |
| 08/26/2004 | US20040166058 Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 08/26/2004 | CA2515424A1 The combined use of cruciferous indoles and chelators for the treatment of papillomavirus-related conditions |
| 08/25/2004 | EP1448994A2 Isotope-coded affinity tag |
| 08/25/2004 | EP1448780A2 Direct targeting binding proteins |
| 08/25/2004 | EP1448588A2 Psma antibodies and protein multimers |
| 08/25/2004 | CN1523039A Monoclonal antibody GDK-1 of anti-cell membrane glucoprotein KD-43 and its iodide DGDK-1 and application |
| 08/24/2004 | US6782289 Methods and apparatus for characterizing lesions in blood vessels and other body lumens |
| 08/24/2004 | US6780397 6,8-bis(phosphinopropylthio)octanoic acid chemical intermediate; cancer and tumor diagnosis; radiopharmaceuticals |
| 08/19/2004 | WO2004070352A2 Methods, mixtures, kits and compositions pertaining to analyte determination |
| 08/19/2004 | WO2004069787A1 Enantiomer-pure (4s,8s)- and (4r, 8r)-4-p-nitrobenzyl-8-methyl-3, 6, 9-triaza-3n, 6n, 9n-tricarboxymethyl-1, 11-undecanoic acid and derivatives thereof, method for producing them, and their use for producing pharmaceutical agents |
| 08/19/2004 | WO2004069365A1 Diagnostic imaging agents with mmp inhibitory activity |
| 08/19/2004 | WO2004069285A1 Improved radiometal complex compositions |
| 08/19/2004 | WO2004069282A1 Conjugates of enantiomer-pure (4s,8s)- and (4r,8r)-4-p-benzyl-8-methyl-3,6,9-triaza-3n,6n,9n-tricarboxymethyl-1,11-undecanoic acid with biomolecules, method for the production thereof and their use for producing pharmaceutical agents |
| 08/19/2004 | WO2004069281A1 Bifunctional molecules comprising at least one integrin-binding and their use in imaging and therapy of angiogenesis and related disorders |
| 08/19/2004 | WO2004069159A2 Vitamin receptor binding drug delivery conjugates |
| 08/19/2004 | WO2004050168A3 Radiopharmaceuticals and radioactive microspheres for locoregional ablation of abnormal tissues |
| 08/19/2004 | WO2004034876A3 Magnetically guided particles for radiative therapies |
| 08/19/2004 | WO2003068919A3 Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation |
| 08/19/2004 | US20040162332 serotonin receptor ligands such as 6-(phenylsulfonyl)-2,3,4,9-tertrahydro-1H-carbazol-3-amine, used for prophylaxis of anxiety, depression, schizophrenia, Alzheimer's disease, panic, phobia, obsessive compulsive disorder, obesity, post-traumatic stress syndrome, epilepsy and nervous system disorders |
| 08/19/2004 | US20040161776 Mixture comprising multimeric prostate specific membrane antigen (PSMA) for use as tools in diagnosis and treatment of cell proliferative disorders |
| 08/19/2004 | US20040161751 A radioactive 32P or 33P phosphine oxide ligand that is useful for radioreceptor binding studies and for diagnostic studies of cancerous tissues; the receptor confers selectively and specificity in delivering lethal radiation to diseased cells |
| 08/19/2004 | US20040161383 Diagnostic agents for pancreatic exocrine function |
| 08/19/2004 | CA2514885A1 Diagnostic imaging agents with mmp inhibitory activity |
| 08/19/2004 | CA2514307A1 Improved radiometal complex compositions |
| 08/19/2004 | CA2512867A1 Vitamin receptor binding drug delivery conjugates |
| 08/18/2004 | EP1446163A2 Multidrug multiligand conjugates for targeted drug delivery |
| 08/18/2004 | EP1350109A4 Marker for inflammatory conditions |
| 08/18/2004 | EP0775160B1 Cyclic hexapeptide somatostatin analogues |
| 08/17/2004 | US6777561 Compounds |
| 08/17/2004 | US6776977 Polypodal chelants for metallopharmaceuticals |
| 08/12/2004 | WO2004066946A2 Method for evaluating the efficacy of certain cancer treatments |
| 08/12/2004 | WO2004066933A2 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 08/12/2004 | WO2004056858A3 Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders |
| 08/12/2004 | WO2003015606A3 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy |
| 08/12/2004 | US20040157953 Materials for filling cavities in the body |
| 08/12/2004 | US20040156844 therapeutic agent is covalently modified with an insoluble component, such as an immunoglobulin construct, that is cleaved by enzymes endogenous to the gastrointestinal tract, but is not susceptible to cleavage by intestinal saccharidases |
| 08/12/2004 | US20040156824 Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof |
| 08/12/2004 | US20040156786 Paramagnetic complexes as contrast agents for magnetic resonance imaging; chelate compounds |
| 08/12/2004 | US20040156781 Polymeric materials for site specific delivery to the body |
| 08/12/2004 | US20040156780 Radiolabeled antibodies for treatment of tumors |
| 08/12/2004 | DE10305463A1 Enantiomerenreines (4S,8S)- und (4R,8R)-4-p-Nitrobenzyl-8-methyl-3,6,9-triza-3N,6N,9N-tricarboxymethyl-1,11-undecandisäure und deren Abkömmlinge, Verfahren zu deren Herstellung und Verwendung zur Herstellung pharmazeutischer Mittel Enantiomerically pure (4S, 8S) - and (4R, 8R) -4-p-nitrobenzyl-8-methyl-3,6,9-triza-3N, 6N, 9N tricarboxymethyl-1,11-undecanedioic acid and its derivatives, method to their preparation and use for the preparation of pharmaceutical compositions |
| 08/12/2004 | DE10305462A1 Konjugate enantiomerenreiner (4S,8S)- und (4R,8R)-4-p-Benzyl-8-methyl-3,6,9-triaza-3N, 6N, 9N-tricarboxymethyl-1,11-undecandisäure mit Biomolekülen, Verfahren zu deren Herstellung und Verwendung zur Herstellung Conjugates of enantiomerically pure (4S, 8S) - and (4R, 8R) -4-p-benzyl-8-methyl-3,6,9-triaza-3N, 6N, 9N tricarboxymethyl-1,11-undecanedioic acid with biomolecules, method to their preparation and use for the preparation of |
| 08/12/2004 | DE10303664A1 Erkennungsmoleküle zur Behandlung und Detektion von Tumoren Recognition molecules for the treatment and detection of tumors |
| 08/12/2004 | CA2514062A1 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 08/12/2004 | CA2513769A1 Method for evaluating the efficacy of certain cancer treatments |
| 08/11/2004 | EP1444990A1 Improved Radiometal Complex Compositions |
| 08/11/2004 | EP1444264A2 Methods and materials for targeting and affecting selected cells |
| 08/11/2004 | EP1443861A2 Tumor targeted photodiagnostic-phototherapeutic agents |
| 08/11/2004 | EP1343533B1 Device for synthesis of radiopharmaceutical products |
| 08/11/2004 | EP0799050B1 Radiolabeled annexin-galactose cluster conjugates |
| 08/11/2004 | EP0787017B1 Diagnostic preparation for detection of helicobacter pylori |
| 08/11/2004 | CN1520315A Solid-phase nucleophilic fluorination |
| 08/11/2004 | CN1519242A Compound of benzopyran category marked by fluorin [*F] as well as preparation method and its application of developing agent for D4 receptor of dopamine |
| 08/10/2004 | US6774278 Coated implantable medical device |
| 08/10/2004 | US6774209 Synthetic, isolated polypeptides overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon; for imaging |
| 08/10/2004 | US6773696 Wherein void comprises vapor of volatile liquid (aliphatic hydrocarbons, chlorofluorocarbons, tetraalkyl silanes, and perfluorocarbons); for computed tomography imaging of the gastrointestinal region |
| 08/10/2004 | US6773673 Radiation handling system and set |
| 08/10/2004 | US6773341 Ventilating device for ventilating through a ridge |
| 08/10/2004 | CA2121041C Composite antibodies of human subgroup iv light chain capable of binding to tag-72 |
| 08/05/2004 | WO2004065621A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 08/05/2004 | WO2004065547A2 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 08/05/2004 | WO2004065423A2 Recognition molecules for the treatment and detection of tumours |